07:00 , Mar 20, 2008 |  BC Innovations  |  Markers

Micro Management

In the past four years, at least two biotechs have released tests that use mRNA-based gene signatures to predict the likelihood of breast cancer recurrence. Now, research is emerging that suggests microRNAs could also have...
07:00 , Jul 2, 2001 |  BC Week In Review  |  Company News

Axis-Shield, Gemini Genomics, Specialty Laboratories Inc. sales and marketing update

GMNI said that marketing and development partner ASD granted SP exclusive U.S. rights to a gene-based osteoporosis screening test based on GMNI's patent on the type 1 collagen ( COL1A1 ) gene. SP expects to...